Halozyme Therapeutics Inc

HALONASDAQ · US

Holders

REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,400 sh · $985.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−3,200 sh · $344.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−5,703 sh · $587.9K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−900 sh · $89.1K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,000 sh · $923.0K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−7,200 sh · $765.8K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−9,600 sh · $1.0M
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
−4,897 sh · $509.8K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDT+7
Torley Helen
Halozyme Therapeutics Inc · NASDAQ
+20,000 sh · $368.2K
Filed 19 Aug 2026SEC Form 4view source